Search

Your search keyword '"SORIANO, Alessandra"' showing total 331 results

Search Constraints

Start Over You searched for: Author "SORIANO, Alessandra" Remove constraint Author: "SORIANO, Alessandra"
331 results on '"SORIANO, Alessandra"'

Search Results

1. Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy

2. Inflammatory bowel diseases: Sex differences and beyond

3. Contributors

7. Proof-of-Concept Human Organ-on-Chip Study: First Step of Platform to Assess Neuro-Immunological Communication Involved in Inflammatory Bowel Diseases

8. Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey

10. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease.

11. Large-Vessel Vasculitis

12. List of Contributors

14. Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study

17. SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves

21. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease

25. List of Contributors

28. Management of colovesical fistula: a systematic review

30. Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach

31. Primary Diffuse Large B-Cell Lymphoma of the Urinary Bladder: Update on a Rare Disease and Potential Diagnostic Pitfalls

33. EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3)

34. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment

35. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1

36. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models)

37. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic–Pathologic Correlations

38. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables

41. Vasculitides

44. EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 1)

45. EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 2)

46. Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy

49. Validation Study of a New Random-Access Chemiluminescence Immunoassay Analyzer i-TRACK10 ® to Monitor Infliximab and Adalimumab Serum trough Levels and Anti-Drug Antibodies.

Catalog

Books, media, physical & digital resources